Publications en collaboration avec des chercheurs de Klinikum der Universität München (2)

2022

  1. Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials

    JTO Clinical and Research Reports, Vol. 3, Núm. 9

2004

  1. Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer

    Lung Cancer, Vol. 46, Núm. 3, pp. 361-368